Santarus, Inc. v. Par Pharmaceutical, Inc.: Is there a new written description requirement for negative limitations?
- Published in:
- Journal of Generic Medicines, 2013, v. 10, n. 1, p. 53, doi. 10.1177/1741134313481035
- By:
- Publication type:
- Article
Works matching DE "SANTARUS Inc."
Results: 3
1
2
Omeprazole/Antacid-Powder Suspension – Santarus: Acitrel, Rapinex® Powder for Oral Suspension, SAN 05.
- Published in:
- Drugs in R&D, 2004, v. 5, n. 4, p. 234
- By:
- Publication type:
- Article
3
FDA actions in brief.
- Published in:
- Formulary, 2006, v. 41, n. 4, p. 173
- Publication type:
- Article